Title: B-Type Natriuretic Peptide<br/>Author: Semhar Tewelde<br/><a href='http://umem.org/profiles/faculty/352/'>[Click to email author]</a><hr/><div class="page" title="Page 1">
        <div class="layoutArea">
                <div class="column">
                        <ul>
                                <li>
                                        <span style="font-family:times new roman,times,serif;">B-type natriuretic peptide (BNP) is a useful prognostic biomarker in patients with reduced LVEF, but data in heart failure (HF) with preserved ejection fraction (HFPEF) is minimal</span></li>
                                <li>
                                        <span style="font-family:times new roman,times,serif;">A recent study sought to determine the prognostic value of BNP in patients with HFPEF in comparison to data in HF patients with reduced left ventricular EF <40%</span></li>
                                <li>
                                        <span style="font-family: 'times new roman', times, serif; ">615 patients with mild to moderate HF were followed for 18 months and BNP was measured at baseline and related to the primary outcomes (mortality and HF hospitalization)</span></li>
                                <li>
                                        <span style="font-family: 'times new roman', times, serif; ">BNP levels were significantly higher in patients with reduced LVEF than in those with HFPEF (p < 0.001), however the risk of adverse outcomes and prognosis in patients with HFPEF is as poor as in those with reduced LVEF  </span></li>
                        </ul>
                        <p>
                                 </p>
                        <p>
                                 </p>
                        <p>
                                 </p>
                        <p>
                                 </p>
                        <p>
                                <span style="font-size: 8pt; font-family: FranklinGothic; "> </span></p>
                </div>
        </div>
</div>
<p>
         </p>
<fieldset><legend>References</legend>

                <p>
        B-Type Natriuretic Peptide and Prognosis in Heart Failure Patients With Preserved and Reduced Ejection Fraction. Veldhuisen D, Linssen G, et al. J Am Coll Cardiol 2013; 61:1498-506</p>
<p>
         </p>
</fieldset>